Innovation Pharmaceuticals Inc (IPIX)

[CallMeCrazy]

tduggan, this is for clarification:

Stephen T. Sonis, DMD, DMSc

Clinical Professor of Oral Medicine at Harvard School of Dental Medicine, Senior Surgeon and Chief, Divisions of Oral Medicine at Brigham and Women's Hospital and the Dana-Farber Cancer Institute, and Chief Scientific Officer of Biomodels, LLC, as well as Scientific Advisory Board Member and Lead Advisor for the Soligenix Phase 2 clinical study of SGX942 for the treatment of oral mucositis in head and neck cancer.

This guy, obviously, wears a lot of hats. I would like to point out that the B-OM studies were done by Dr. Sonis in his capacity as Chief Scientific Officer of Biomodels, LLC. Additionally, his role as Lead Advisor in a P2 clinical trial for a competing drug would probably disqualify him from any participation in B-OM clinical trials, no matter where held. I do not have knowledge that this true only that it seems LOGICAL to me.